[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2113975T3 - Azida de tri-alquil superior-estaño y su uso. - Google Patents

Azida de tri-alquil superior-estaño y su uso.

Info

Publication number
ES2113975T3
ES2113975T3 ES93110458T ES93110458T ES2113975T3 ES 2113975 T3 ES2113975 T3 ES 2113975T3 ES 93110458 T ES93110458 T ES 93110458T ES 93110458 T ES93110458 T ES 93110458T ES 2113975 T3 ES2113975 T3 ES 2113975T3
Authority
ES
Spain
Prior art keywords
compound
azida
alquil
tri
superior
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93110458T
Other languages
English (en)
Inventor
Takeshi Kato
Yasushi Shida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ES2113975T3 publication Critical patent/ES2113975T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/22—Tin compounds
    • C07F7/2284—Compounds with one or more Sn-N linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Saccharide Compounds (AREA)

Abstract

SE PRESENTAN UN COMPUESTO DE LA FORMULA (R)3SNN3, EN LA QUE R ES UN ALKILO C7C18, Y UN PROCESO PARA PRODUCIR UN COMPUESTO DE TETRAZOLILBENCENO QUE CONSISTEN EN REACCIONAR UN COMPUESTO DE CIANOBENCENO CON (R)3SNN3. ESTE PROCESO ES UTIL PARA UNA PRODUCCION SEGURA Y COMERCIALMENTE RENTABLE DEL COMPUESTO DE TETRAZOLILBENCENO QUE SE EMPLEA PARA PRODUCIR UN DERIVADO DE TETRAZOL QUE TIENE UNA ACCION HIPOTENSA BASADA EN UNA ACTIVIDAD DE ANTAGONIZACION -II DE ANGIOTENSINA O UN PRODUCCION INTERMEDIA DE ESTA.
ES93110458T 1992-07-06 1993-06-30 Azida de tri-alquil superior-estaño y su uso. Expired - Lifetime ES2113975T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17848492 1992-07-06

Publications (1)

Publication Number Publication Date
ES2113975T3 true ES2113975T3 (es) 1998-05-16

Family

ID=16049275

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93110458T Expired - Lifetime ES2113975T3 (es) 1992-07-06 1993-06-30 Azida de tri-alquil superior-estaño y su uso.

Country Status (8)

Country Link
US (2) US5484955A (es)
EP (1) EP0578125B1 (es)
AT (1) ATE164584T1 (es)
CA (1) CA2099822C (es)
DE (1) DE69317704T2 (es)
DK (1) DK0578125T3 (es)
ES (1) ES2113975T3 (es)
GR (1) GR3026737T3 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO304429B1 (no) * 1992-12-17 1998-12-14 Sankyo Co Bifenylderivater, farmas°ytisk preparat og deres anvendelse for fremstilling av et medikament for behandling av hypertensjon og hjertesykdom
JPH08325248A (ja) * 1995-05-26 1996-12-10 Chugoku Kayaku Kk テトラゾール類の新規な合成試薬及びそれを用いたテトラゾール類の製造方法
JP3671266B2 (ja) * 1996-03-21 2005-07-13 東洋化成工業株式会社 ５−置換テトラゾール類の製造方法
WO2002043709A1 (fr) 2000-12-01 2002-06-06 Takeda Chemical Industries, Ltd. Procede de production d'une preparation contenant une substance bioactive
EP1444988A4 (en) 2001-11-13 2007-04-25 Takeda Pharmaceutical CANCER AGENT
AU2003228767A1 (en) * 2002-04-29 2003-11-17 Teva Pharmaceutical Industries Ltd. Processes for preparing losartan and losartan potassium
CN100418962C (zh) * 2002-10-28 2008-09-17 南京长澳医药科技有限公司 一种厄贝沙坦合成工艺
GB0316546D0 (en) 2003-07-15 2003-08-20 Novartis Ag Process for the manufacture of organic compounds
WO2005051929A1 (en) * 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited Conversion of aromatic nitriles into tetrazoles
US7923566B2 (en) 2005-08-16 2011-04-12 Suven Life Sciences Limited Alternative process for the preparation of losartan
WO2007026375A1 (en) * 2005-08-31 2007-03-08 Suven Life Sciences Process for the preparation of losartan
EP1764365A1 (en) * 2005-09-20 2007-03-21 KRKA, D.D., Novo Mesto A process for the preparation of sartan derivates and intermediates useful in such process
KR100701420B1 (ko) * 2006-01-06 2007-03-30 (주)다산메디켐 비페닐테트라졸 유도체의 제조방법
KR100809159B1 (ko) * 2006-05-15 2008-02-29 한미약품 주식회사 로사탄의 개선된 제조방법
US8459525B2 (en) 2008-02-14 2013-06-11 Ethicon Endo-Sugery, Inc. Motorized surgical cutting and fastening instrument having a magnetic drive train torque limiting device
US8623928B2 (en) 2009-11-12 2014-01-07 National Research Council Of Canada Polymers of intrinsic microporosity containing tetrazole groups

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3232958A (en) * 1961-11-03 1966-02-01 American Potash & Chem Corp Metalloid azides and process for preparing the same
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
GB9017479D0 (en) * 1990-08-09 1990-09-26 Ici Plc Process

Also Published As

Publication number Publication date
DE69317704T2 (de) 1998-07-23
CA2099822C (en) 2003-12-16
DK0578125T3 (da) 1999-01-04
US5599943A (en) 1997-02-04
GR3026737T3 (en) 1998-07-31
DE69317704D1 (de) 1998-05-07
US5484955A (en) 1996-01-16
EP0578125B1 (en) 1998-04-01
EP0578125A1 (en) 1994-01-12
CA2099822A1 (en) 1994-01-07
ATE164584T1 (de) 1998-04-15

Similar Documents

Publication Publication Date Title
ES2113975T3 (es) Azida de tri-alquil superior-estaño y su uso.
MY138525A (en) Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
HU910847D0 (en) Process for producing chloro-triazole derivatives
NO307379B1 (no) 3-merkapto-1-(1,3-tiazolin-2-yl)azetidin-derivater
FI913640A (fi) Foerfarande foer framstaellning av nitriler.
ES2162367T3 (es) Metodo de produccion de un compuesto de aminobenceno.
ATE115580T1 (de) Verfahren und zwischenprodukte zur herstellung von azabicyclo(2.2.2>octan-3-iminen.
PL308545A1 (en) Novel substituted azethydinones as anti-inflammatory and anti-degenerative agents
EP0829473A4 (en) PROCESSES FOR THE PREPARATION OF CYCLIC COMPOUNDS
EP0861842A4 (en) NOVEL WATER-SOLUBLE DERIVATIVE OF FLUOROETHYLCAMPTOTHECIN AND PROCESS FOR PRODUCING THE SAME
ATE245147T1 (de) Substituierte aminochinazolinon (thion) derivate
GR3029836T3 (en) Process for producing n-biphenylmethylthiadiazoline derivative or salt thereof and intermediate for producing the same
DE69737376D1 (de) Verfahren zur Synthese einer Oxonolverbindung
AU8452591A (en) 2-thio-1-aminocarbonyl cyclo alk-1-enes
ES550040A0 (es) Un metodo para producir derivados de acido 2-(4-amino susti-tuido-3-oxo-2-isoxazolidinil)-5-oxo-2-tetrahidrofuran-carbo-xilico
ATE28748T1 (de) 2-brom-4-methylimidazol-5-karbonsaeure-ester.
ATE206109T1 (de) Verfahren zur herstellung von carbamoylmethylharnstoff-derivaten
PT837066E (pt) Processo aperfeicoado para a producao de ester de penicilina g
TH12632EX (th) สารประกอบเฮเทอโรไซคลิค
ATE244228T1 (de) Verfahren zur herstellung von chloroacetylaminothiazoleaceticsäure derivate

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 578125

Country of ref document: ES